This webinar will provide an overview of the latest knowledge about pharmaceuticals and their effects on the environment and what pharmacists can do to prevent these problems.
Medicines are crucial tools to prevent or treat diseases, but there is growing evidence that residuals of pharmaceuticals can also be found in the water, atmosphere or soil, with possibly negative impact on the environment and health. Similarly, activities associated with the research, development, production, distribution and dispensing of medicines may also have an impact on the environment.
This impact is a challenge of global significance, and one in which individual pharmacists and professional associations can provide leadership that makes a difference. Throughout the pharmaceuticals supply chain efforts can be made to mitigate the negative impact of pharmaceuticals and related activities on the environment.

Learning objectives:
After this webinar the participants should be able to
1. Understand mechanisms how APIs end in the environment
2. Understand what kind of problems APIs cause for the environment
3. Get ideas and models of how pharmacists can prevent these problems

Facilitator:
Gonçalo Sousa Pinto, FIP Lead for Practice Development and Transformation - the Netherlands

Speakers:
1. Eeva Teräsalmi, FIP Vice President - Finland
2. Jaakko Teppo, Researcher and member of the Generation Green working group, University of Helsinki Division of Pharmaceutical Chemistry and Technology - Finland

The webinar will start with an overview of the ongoing clinical research undertaken to assess potential candidates for COVID-19 treatment. This will be followed by presenting the findings of a systematic literature review undertaken to identify the major factors affecting the cost effectiveness of antivirals for the treatment of pandemic influenza. The key considerations in the development of treatmets for COVID19 will then be summarised, in light of these findings, including considerations around safety, efficacy, costs and pricing.

Learning objectives:

- To evaluate the current state of clinical research and the potential for developing curative treatments for COVID 19

- To summarise the key consideration when developing treatments for pandemic influenza

- To assess the potential clinical and economic value of COVID19 treatments

Misinformation regarding vaccines, lack of understanding regarding their important benefits, and limiting fears and beliefs are factors that present challenges to vaccination. The amount of misinformation about vaccines circulating on the Internet in recent years has generated a worrying level of hesitancy or outright opposition to the use of vaccines by growing anti-vaccination groups in many countries. This has been associated with the return or increase of diseases such as measles and whooping cough. Pharmacists play a critical role in building confidence in vaccines and providing evidence-based advice.

Learning Objectives:

After this webinar the participants should have a better understanding of the following topics:

1. (Dis)trust in medicines and vaccines
2. Benefits of vaccines
3. Evidence-based advice through pharmacist
4. Vaccination and quality of life for older adults
5. Engaging with members of the public in a meaningful way
6. How to interact efficiently with patients in a very short time